EU’s Slow Start in the Vaccine Race
By procuring COVID-19 vaccines together, EU Member States ensured that they would have equal access to them. However, the EU concluded contracts with producers later then the UK and the U.S., which, as pharmaceutical companies hit production snags, continued to receive deliveries, unlike the Member States. This delay will affect more than just the countries involved because a slower vaccine rollout could weaken public support for the Union and its international standing.
More...